InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,344.39
(
0.00%
)
US TECH 100
18,134.80
(
0.44%
)
Dow Jones
39,357.01
(
0.00%
)
Brent Oil
81.45
(
-0.20%
)
Bitcoin
58,955.63
(
-0.67%
)
Post# of 252864
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 68
Posts 4505
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: DewDiligence post# 130075

Wednesday, 11/02/2011 8:39:10 PM

Wednesday, November 02, 2011 8:39:10 PM

Post# of 252864

TEVA said it would be "premature" to submit an NDA at this time for laquinimod and will be working with FDA to design an additional trial for the relapsing-remitting multiple sclerosis (RRMS) product.



http://www.biocentury.com/dailynews/company/2011-11-02/teva-says-laquinimod-nda-submission-premature

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up